Cargando…

Real-time reverse transcription-polymerase chain reaction assay panel for the detection of severe acute respiratory syndrome coronavirus 2 and its variants

BACKGROUND: With the ongoing worldwide coronavirus disease 2019 (COVID-19) pandemic, an increasing number of viral variants are being identified, which poses a challenge for nucleic acid-based diagnostic tests. Rapid tests, such as real-time reverse transcription-polymerase chain reaction (rRT-PCR),...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Rou-Jian, Zhao, Li, Huang, Bao-Ying, Ye, Fei, Wang, Wen-Ling, Tan, Wen-Jie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8439998/
https://www.ncbi.nlm.nih.gov/pubmed/34402479
http://dx.doi.org/10.1097/CM9.0000000000001687
_version_ 1783752621140475904
author Lu, Rou-Jian
Zhao, Li
Huang, Bao-Ying
Ye, Fei
Wang, Wen-Ling
Tan, Wen-Jie
author_facet Lu, Rou-Jian
Zhao, Li
Huang, Bao-Ying
Ye, Fei
Wang, Wen-Ling
Tan, Wen-Jie
author_sort Lu, Rou-Jian
collection PubMed
description BACKGROUND: With the ongoing worldwide coronavirus disease 2019 (COVID-19) pandemic, an increasing number of viral variants are being identified, which poses a challenge for nucleic acid-based diagnostic tests. Rapid tests, such as real-time reverse transcription-polymerase chain reaction (rRT-PCR), play an important role in monitoring COVID-19 infection and controlling its spread. However, the changes in the genotypes of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants may result in decreased sensitivity of the rRT-PCR assay and it is necessary to monitor the mutations in primers and probes of SARS-CoV-2 detection over time. METHODS: We developed two rRT-PCR assays to detect the RNA-dependent RNA polymerase (RdRp) and nucleocapsid (N) genes of SARS-CoV-2. We evaluated these assays together with our previously published assays targeting the ORF1ab and N genes for the detection and confirmation of SARS-CoV-2 and its variants of concern (VOCs). In addition, we also developed two rRT-PCR assays (S484K and S501Y) targeting the spike gene, which when combined with the open reading frames (ORF)1ab assay, respectively, to form duplex rRT-PCR assays, were able to detect SARS-CoV-2 VOCs (lineages B.1.351 and B.1.1.7). RESULTS: Using a SARS-CoV-2 stock with predetermined genomic copies as a standard, the detection limit of both assays targeting RdRp and N was five copies/reaction. Furthermore, no cross-reactions with six others human CoVs (229E, OC43, NL63, HKU1, severe acute respiratory syndrome coronavirus and Middle East respiratory syndrome coronavirus) were observed using these assays. In addition, the S484K and S501Y assays were combined with the ORF1ab assay, respectively. CONCLUSIONS: Four rRT-PCR assays (RdRp, N, S484K, and S501Y) were used to detect SARS-CoV-2 variants, and these assays were shown to be effective in screening for multiple virus strains.
format Online
Article
Text
id pubmed-8439998
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-84399982021-09-20 Real-time reverse transcription-polymerase chain reaction assay panel for the detection of severe acute respiratory syndrome coronavirus 2 and its variants Lu, Rou-Jian Zhao, Li Huang, Bao-Ying Ye, Fei Wang, Wen-Ling Tan, Wen-Jie Chin Med J (Engl) Original Articles BACKGROUND: With the ongoing worldwide coronavirus disease 2019 (COVID-19) pandemic, an increasing number of viral variants are being identified, which poses a challenge for nucleic acid-based diagnostic tests. Rapid tests, such as real-time reverse transcription-polymerase chain reaction (rRT-PCR), play an important role in monitoring COVID-19 infection and controlling its spread. However, the changes in the genotypes of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants may result in decreased sensitivity of the rRT-PCR assay and it is necessary to monitor the mutations in primers and probes of SARS-CoV-2 detection over time. METHODS: We developed two rRT-PCR assays to detect the RNA-dependent RNA polymerase (RdRp) and nucleocapsid (N) genes of SARS-CoV-2. We evaluated these assays together with our previously published assays targeting the ORF1ab and N genes for the detection and confirmation of SARS-CoV-2 and its variants of concern (VOCs). In addition, we also developed two rRT-PCR assays (S484K and S501Y) targeting the spike gene, which when combined with the open reading frames (ORF)1ab assay, respectively, to form duplex rRT-PCR assays, were able to detect SARS-CoV-2 VOCs (lineages B.1.351 and B.1.1.7). RESULTS: Using a SARS-CoV-2 stock with predetermined genomic copies as a standard, the detection limit of both assays targeting RdRp and N was five copies/reaction. Furthermore, no cross-reactions with six others human CoVs (229E, OC43, NL63, HKU1, severe acute respiratory syndrome coronavirus and Middle East respiratory syndrome coronavirus) were observed using these assays. In addition, the S484K and S501Y assays were combined with the ORF1ab assay, respectively. CONCLUSIONS: Four rRT-PCR assays (RdRp, N, S484K, and S501Y) were used to detect SARS-CoV-2 variants, and these assays were shown to be effective in screening for multiple virus strains. Lippincott Williams & Wilkins 2021-09-05 2021-08-16 /pmc/articles/PMC8439998/ /pubmed/34402479 http://dx.doi.org/10.1097/CM9.0000000000001687 Text en Copyright © 2021 The Chinese Medical Association, produced by Wolters Kluwer, Inc. under the CC-BY-NC-ND license. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/)
spellingShingle Original Articles
Lu, Rou-Jian
Zhao, Li
Huang, Bao-Ying
Ye, Fei
Wang, Wen-Ling
Tan, Wen-Jie
Real-time reverse transcription-polymerase chain reaction assay panel for the detection of severe acute respiratory syndrome coronavirus 2 and its variants
title Real-time reverse transcription-polymerase chain reaction assay panel for the detection of severe acute respiratory syndrome coronavirus 2 and its variants
title_full Real-time reverse transcription-polymerase chain reaction assay panel for the detection of severe acute respiratory syndrome coronavirus 2 and its variants
title_fullStr Real-time reverse transcription-polymerase chain reaction assay panel for the detection of severe acute respiratory syndrome coronavirus 2 and its variants
title_full_unstemmed Real-time reverse transcription-polymerase chain reaction assay panel for the detection of severe acute respiratory syndrome coronavirus 2 and its variants
title_short Real-time reverse transcription-polymerase chain reaction assay panel for the detection of severe acute respiratory syndrome coronavirus 2 and its variants
title_sort real-time reverse transcription-polymerase chain reaction assay panel for the detection of severe acute respiratory syndrome coronavirus 2 and its variants
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8439998/
https://www.ncbi.nlm.nih.gov/pubmed/34402479
http://dx.doi.org/10.1097/CM9.0000000000001687
work_keys_str_mv AT luroujian realtimereversetranscriptionpolymerasechainreactionassaypanelforthedetectionofsevereacuterespiratorysyndromecoronavirus2anditsvariants
AT zhaoli realtimereversetranscriptionpolymerasechainreactionassaypanelforthedetectionofsevereacuterespiratorysyndromecoronavirus2anditsvariants
AT huangbaoying realtimereversetranscriptionpolymerasechainreactionassaypanelforthedetectionofsevereacuterespiratorysyndromecoronavirus2anditsvariants
AT yefei realtimereversetranscriptionpolymerasechainreactionassaypanelforthedetectionofsevereacuterespiratorysyndromecoronavirus2anditsvariants
AT wangwenling realtimereversetranscriptionpolymerasechainreactionassaypanelforthedetectionofsevereacuterespiratorysyndromecoronavirus2anditsvariants
AT tanwenjie realtimereversetranscriptionpolymerasechainreactionassaypanelforthedetectionofsevereacuterespiratorysyndromecoronavirus2anditsvariants